首页> 外文期刊>Journal of Agricultural and Food Chemistry >Immunomodulatory Activity of Polysaccharide-Protein Complex from the Mushroom Sclerotia of Polyporus rhinocerus in Murine Macrophages
【24h】

Immunomodulatory Activity of Polysaccharide-Protein Complex from the Mushroom Sclerotia of Polyporus rhinocerus in Murine Macrophages

机译:猪巨噬细胞中猪鼻菌核菌菇菌核多糖-蛋白复合物的免疫调节活性

获取原文
获取原文并翻译 | 示例
           

摘要

A novel water-soluble polysaccharide-protein complex (PRW1) isolated from the sclerotia of an edible mushroom Polyporus rhinocerus which was purified by membrane ultrafiltration could significantly activate murine macrophages RAW264.7 in vitro. PRW1 had a molecular weight of less than SO kDa and was found to be a highly branched heteropolysaccharide-protein complex composed of 45.7 +/- 0.97% polysaccharide and 44.2 +/- 0.41% protein. Based on the results of total acid hydrolysis, methylation analysis, and Fourier transform infrared spectroscopy, the carbohydrate moiety of PRW1 was found to be a beta-D-mannoglucan with its backbone containing -> 1)-D-Glcp-(4 ->, -> 1)-D-Glcp-(6 ->, and -> 1)-D-Manp-(2 -> residues (molar ratio of 5:4:6) and having terminal D-Glcp as side chain (degree of branching of 0.62). In vitro studies showed that PRW1 significantly induced NO production and enhanced the release of a variety of cytokines including G-CSF, GM-CSF, IL-6, IL12p40/70, MCP-1, MCP-5, MIP-1-alpha, MIP-2, RANTES, sTNFRI, and TNF-alpha. Mechanistically, PRW1 treatment triggered ERK phosphorylation to activate macrophages within 15 min and significantly increased the expression level of inducible NOS after 6 h. In summary, this study indicates that PRW1 derived from the sclerotia of P. rhinocerus is a potential immunomodulatory agent for cancer immunotherapy.
机译:通过膜超滤纯化的可食用蘑菇猪鼻菌的菌核中分离出的新型水溶性多糖蛋白复合物(PRW1)可以在体外显着激活鼠巨噬细胞RAW264.7。 PRW1的分子量小于SO kDa,并且是由45.7 +/- 0.97%的多糖和44.2 +/- 0.41%的蛋白质组成的高度分支的杂多糖-蛋白质复合物。根据总酸水解,甲基化分析和傅立叶变换红外光谱的结果,发现PRW1的碳水化合物部分是β-D-甘露聚糖,其骨架包含-> 1)-D-Glcp-(4-> ,-> 1)-D-Glcp-(6->和-> 1)-D-Manp-(2->残基(摩尔比为5:4:6),并且末端D-Glcp为侧链(分支度为0.62)。体外研究表明PRW1显着诱导NO生成并增强了多种细胞因子的释放,包括G-CSF,GM-CSF,IL-6,IL12p40 / 70,MCP-1,MCP-5 ,MIP-1-alpha,MIP-2,RANTES,sTNFRI和TNF-alpha机理上,PRW1处理在15分钟内触发了ERK磷酸化以激活巨噬细胞,并在6小时后显着提高了诱导型NOS的表达水平。研究表明,源自P. Rhinocerus菌核的PRW1是一种潜在的免疫调节剂,可用于癌症免疫治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号